Engineering the Future of Lifesciences

We are the strategic operating partner that the world’s leading biopharma companies - including all 20 of the Top 20 - rely on to design, run and continuously evolve the commercial, medical, clinical and consulting workflows that determine whether a new therapy reaches the right physician, the right patient, in the right way, fast enough to matter.

Every industry transformation of the past three decades - the shift to digital HCP engagement, the rebuild of regulated content for compliance and scale, the consolidation of the global commercialization supply chain - Indegene led from inside the workflow rather than from the sidelines of an advisory engagement. AI is the next such transformation, and it is the most defining of them all.

Across our four enterprise offering areas, we embed AI into the regulated workflows we have run for the industry for over a quarter of a century, take accountability for business outcomes that matter - intelligent clinical trials, faster regulatory approvals, effective product launches, personalized omnichannel experiences, lifecycle optimization, and revenue augmentation - and combine deep domain expertise, a life sciences-native operating system, and a global operating model to turn industry complexity into client advantage.

Enterprise Commercial Solutions

Our Enterprise Commercial Solutions (ECS) help biopharma companies maximize value across the brand and product lifecycle - from first launch to loss of exclusivity and beyond. We connect the entire commercial value chain - from audience intelligence, brand strategy and creative concepting through content production, campaign operations and omnichannel engagement - as a single accountable execution partner, while helping clients identify and engage hard-to-reach patient populations, particularly in rare diseases and specialty therapeutic areas.

Our Launch Engine enables first-time commercialization by standing up end-to-end commercial capabilities - from strategy to execution - in weeks rather than years, particularly for emerging biotech and mid-sized pharmaceutical companies entering the US and global markets. For growth and established brands, we improve commercial performance through AI-embedded operating models that strengthen brand value across the lifecycle, increasing the productivity of every commercial dollar across content, channels and customer interactions.

Further, as the industry prepares for revenue impact from loss-of-exclusivity pressure by 2030, while simultaneously demanding greater commercial productivity per dollar invested, ECS helps clients design and run commercial operations that are faster, more effective and structurally more cost-efficient than the fragmented, brand-by-brand model the industry inherited.

We have sharpened our strategic agenda for the AI decade around six interlocking commercial priorities.

• Scaling our agentic operating partner construct into a category-creating capability - offered as an operating partner, an operating system and as custom solutions configured to each client’s AI agenda
• Executing omnichannel from strategy through activation, anchored on the audience intelligence built into our proprietary Invisage™ and Tandem™ platforms
• Delivering an integrated ‘strategy-to-execution’ commercial operations partnership that closes the gap between brand intent and field reality
• Scaling content at enterprise scale - with embedded compliance and Generative Engine Optimization (GEO) to ensure brand visibility in an AI-mediated search era spanning ChatGPT, Perplexity, Gemini and the next wave of agentic interfaces
• Building the Audience Intelligence and Agentic Data Layer - including our agentic semantic layer for field force optimization and patient finding, deepened through partnerships with, for example, Datavant and Komodo, for real-world data depth
• Leading the commercial technology platform transformation that is reshaping enterprise CRM, marketing automation and AI-agent ecosystems across our largest clients

AI is embedded across every layer of our commercial operations - from agentic agency-of-record models that compress weeks of creative development into days, to intelligent content creation, omnichannel campaign operations and AI competency centers - combining human expertise with automation to improve speed, consistency, and business outcomes for our clients and the patients they serve.

Enterprise Medical Solutions

Our Enterprise Medical Solutions (EMS) reimagine the patient evidence value chain - transforming how regulatory affairs, medical affairs, compliance, safety and real-world evidence functions operate across the R&D-to-launch continuum. As organizations focus on shortening the journey from clinical development to patient impact, fragmented workflows, data silos and evolving regulatory requirements continue to slow execution. The disconnected nature of data and information from diverse sources - regulatory, medical, payer, competitive, field and patient - leads to fragmented insights and sub-optimal strategy and responsiveness. EMS embeds AI into critical R&D and medical workflows and helps establish a connected data foundation that improves speed, quality and decision-making at every step.

Our medium-term ambition for EMS is to materially compress the time from clinical trial to peak commercial value for our clients - translating that ambition into the workflows our clients run every day. We are re-engineering database lock to first regulatory submission for radical timeline compression, accelerating first-patient-in to decisive evidence well beyond current industry norms, meaningfully reducing the time from approval to informed patient use, and establishing a zero-surprise compliance environment at a structurally lower cost of operations. These are the operational targets against which we are reshaping every EMS workflow, supported by our NEXT family of AI-native platforms - including NEXT MLR, NEXT Medical Writing Platform and NEXT Scientific Content Authoring - already in production across leading pharmaceutical companies.

Our compliance and safety solutions leverage purpose-built AI to streamline pharmacovigilance and proactive risk management within rigorous regulatory guardrails - elevating human roles from the mundane to those of supervision and judgment. We are progressively re-engineering medico-legal review for sub-24-hour turnaround and embedding agentic safety operations that automate adverse-event processing, signal detection and aggregate reporting, while raising the bar on compliance rather than relaxing it.

Put together, through our EMS suite, we deliver faster evidence generation, stronger compliance, more effective scientific engagement, and better outcomes for our clients and the patients they serve.

Indegene Consulting

With Indegene Consulting, we partner with life sciences organizations to redesign operating models and translate strategy into enterprise execution. Combining deep industry expertise with capabilities in business design, customer experience, digital, data, AI and change management, our practitioners work alongside clients from strategy through implementation and adoption - building capabilities that deliver lasting business value rather than reports that gather dust.

Increasingly, our consulting engagements are anchored on a single defining question for our clients: how does an AI-native, agentic operating model reshape the function - commercial, medical, R&D or enterprise - and what does it take to get there in months rather than years. We lead with an AI Operating Model Assessment that diagnoses where current operations are losing value, identifies the highest-conviction workflows for embedded AI, and produces a sequenced transformation roadmap. We then partner on frontier transformation pilots - including ground-up R&D AI transformations of the kind we are progressing with select strategic clients - and bring those pilots to scale through the same operating muscle we deploy in our commercial, medical and clinical solutions.

Enterprise Clinical Solutions

Our capabilities combine real-world data, omnichannel patient engagement, nurse-navigator-led screening, AI-powered patient identification, GenAI-enabled engagement, agentic screening workflows and always-on patient communities to support connected clinical operations at enterprise scale. Through partnerships with Datavant and Komodo for example, and through our proprietary engagement platforms, we bring depth of data and reach of channels that few partners in the industry can match. Further, by synthesizing clinical, regulatory, medical, patient and payer insights, we help clients optimize clinical trial protocols, accelerate site activation and enable AI-powered clinical data management.

In the year ahead, we will sharpen our game plan for clinical and patient operations - investing in proprietary platforms, building partnerships that strengthen our data and patient-engagement reach, and embedding AI more deeply into clinical workflows - to position Indegene as the strategic operating partner of choice for biopharma sponsors who are reimagining how clinical trials are designed and delivered.